RWA
EW icon

Redhawk Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Redhawk Wealth Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,486
Closed -$1.23M – 175
2022
Q1 		$1.23M Buy
10,486
+3,322
+46% +$373K 0.33% 60
2021
Q4 		$928K Buy
7,164
+994
+16% +$116K 0.24% 78
2021
Q3 		$699K Buy
+6,170
New +$704K 0.19% 92
2020
Q1 		– Sell
-6,621
Closed -$515K – 167
2019
Q4 		$515K Buy
+6,621
New +$517K 0.19% 87

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Redhawk Wealth Advisors's EW Position: Q2 2022 in Review

Redhawk Wealth Advisors sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 10,486 shares — an estimated $1.23M sold.

Redhawk Wealth Advisors first reported a position in EW in Q4 2019 and held it in 4 quarters. The position peaked at $1.23M in Q1 2022. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Redhawk Wealth Advisors reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 10,486 Edwards Lifesciences shares in Q2 2022, an estimated $1.23M.
  • Redhawk Wealth Advisors first reported a position in Edwards Lifesciences in Q4 2019 and held it in 4 quarters.
  • Redhawk Wealth Advisors's Edwards Lifesciences position peaked at $1.23M in Q1 2022.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2022, filed 25 Aug 2022.